LITALGIN

Main information

  • Trade name:
  • LITALGIN tablet
  • Pharmaceutical form:
  • tablet
  • Prescription type:
  • Prescription only
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • LITALGIN tablet
    Finland
  • Language:
  • English

Therapeutic information

  • Therapeutic area:
  • Pitofenone and analgesics
  • Product summary:
  • Suitability for use in older adult patients Pitofenoni hydrochloridum Avoid use in older persons. Slightly anticholinergic. Significant adverse effects include xerostomia, constipation, dizziness, tachycardia, urinary difficulties, confusion and cognitive disorder. Weakens the efficacy of anti-Alzheimer`s drugs. Metamizolum natricum Avoid use in older persons. Non-selective anti-inflammatory analgesic; there are reports of bone marrow suppression and agranulocytosis in addition to the usual adverse effects of anti-inflammatory drugs. Elimination slowed down in renal insufficiency.

Status

  • Source:
  • Fimea
  • Authorization status:
  • Marketing authorization granted
  • Authorization number:
  • 3389
  • Authorization date:
  • 02-11-2007
  • Last update:
  • 21-02-2018